Condensed Consolidated Balance Sheets - USD ($)		Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents		$ 7,895,827	$ 10,935,352
Prepaid expenses and other current assets		301,620	11,041
Deferred offering costs		60,000
Total current assets		8,257,447	10,946,393
Total assets		8,257,447	10,946,393
Current liabilities
Accounts payable		784,029	908,577
Accrued expenses		579,462	906,469
Insurance premium financing liability		200,048
Total current liabilities		1,563,539	1,815,046
Total liabilities		1,563,539	1,815,046
Commitments and contingencies (see Note 5)
Stockholders’ equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of June 30, 2024 and December 31, 2023
Common stock, $0.0001 par value, 250,000,000 shares Authorized, 1,095,346 shares and 884,720 shares issued and 1,095,100 shares and 884,474 shares outstanding as of June 30, 2024 and December 31, 2023, respectively	[1]	111	89
Additional paid-in capital		36,048,454	33,904,749
Accumulated deficit		(29,284,692)	(24,703,526)
Treasury stock, at cost, 246 shares held in treasury as of June 30, 2024 and December 31, 2023		(69,965)	(69,965)
Total stockholders’ equity		6,693,908	9,131,347	[2]
Total liabilities and stockholders’ equity		$ 8,257,447	$ 10,946,393

[1] Amounts have been retroactively restated to reflect the 1-for-15 reverse stock split effectuated on May 24, 2024 (See Note 2 to the condensed consolidated financial statements).

[2] Amounts have been retroactively restated to reflect the 1-for-15 reverse stock split effectuated on May 24, 2024 (See Note 2 to the condensed consolidated financial statements).